IC
BSX icon

IEQ Capital’s Boston Scientific BSX Stock Holding History

IEQ Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
387,250
+74,591
+24% +$4.05M 0.08% 241
2026
Q1 		$19.6M Buy
312,659
+232,814
+292% +$18.6M 0.09% 219
2025
Q4 		$7.61M Sell
79,845
-33,942
-30% -$3.33M 0.02% 416
2025
Q3 		$11.1M Sell
113,787
-9,805
-8% -$1.02M 0.03% 303
2025
Q2 		$13.3M Buy
123,592
+60,860
+97% +$6.16M 0.08% 191
2025
Q1 		$6.33M Sell
62,732
-8,149
-11% -$821K 0.05% 286
2024
Q4 		$6.33M Sell
70,881
-542
-0.8% -$47.7K 0.06% 224
2024
Q3 		$5.99M Buy
71,423
+8,085
+13% +$637K 0.07% 175
2024
Q2 		$4.88M Buy
63,338
+6,182
+11% +$452K 0.07% 187
2024
Q1 		$3.91M Buy
57,156
+5,012
+10% +$322K 0.06% 215
2023
Q4 		$3.01M Buy
52,144
+2,006
+4% +$107K 0.05% 226
2023
Q3 		$2.65M Sell
50,138
-108
-0.2% -$5.66K 0.05% 209
2023
Q2 		$2.72M Buy
50,246
+9,140
+22% +$477K 0.05% 218
2023
Q1 		$2.06M Buy
41,106
+784
+2% +$36.9K 0.05% 247
2022
Q4 		$1.87M Buy
40,322
+2,126
+6% +$92.1K 0.05% 250
2022
Q3 		$1.48M Buy
38,196
+12,440
+48% +$499K 0.04% 281
2022
Q2 		$960K Sell
25,756
-5,138
-17% -$209K 0.03% 313
2022
Q1 		$1.37M Buy
30,894
+7,022
+29% +$304K 0.03% 270
2021
Q4 		$1.01M Sell
23,872
-789
-3% -$33.2K 0.02% 303
2021
Q3 		$1.07M Buy
24,661
+2,590
+12% +$115K 0.03% 289
2021
Q2 		$944K Buy
22,071
+3,464
+19% +$146K 0.03% 262
2021
Q1 		$719K Buy
18,607
+7,665
+70% +$290K 0.03% 244
2020
Q4 		$393K Sell
10,942
-4,128
-27% -$149K 0.02% 200
2020
Q3 		$575K Buy
15,070
+7,488
+99% +$289K 0.03% 219
2020
Q2 		$266K Sell
7,582
-10,128
-57% -$365K 0.02% 255
2020
Q1 		$578K Buy
17,710
+1,819
+11% +$71.1K 0.05% 183
2019
Q4 		$718K Buy
+15,891
New +$665K 0.06% 181

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

IEQ Capital's BSX Position: Q2 2026 in Review

IEQ Capital increased its Boston Scientific (BSX) stake by 24% in Q2 2026, buying an estimated $4.05M and bringing the position to 387,250 shares worth $16.5M. The position accounts for 0.08% of the portfolio, ranked #241.

IEQ Capital first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $19.6M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • IEQ Capital held 387,250 shares of Boston Scientific worth $16.5M as of Q2 2026.
  • IEQ Capital bought 74,591 Boston Scientific shares in Q2 2026, an estimated $4.05M.
  • Boston Scientific made up 0.08% of IEQ Capital's portfolio in Q2 2026, its #241 holding.
  • IEQ Capital first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • IEQ Capital's Boston Scientific position peaked at $19.6M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.